Correlation between RAGE, AGE and PFT. AGE: advanced glycation end-product, cHP: chronic hypersensitivity pneumonitis, DLCO: diffusing capacity for carbon monoxide, fNSIP: fibrotic non-specific interstitial pneumonia, FVC: forced vital capacity, IPF: idiopathic pulmonary fibrosis, r: correlation coefficient, R2: coefficient of determination, sRAGE: soluble receptor for advanced glycation end-products, TLC: Total lung capacity. (*) p-value <â0.05, (**) p-value <â0.01. (XLSX 9 kb
Table S1. Top 25 upregulated genes in IPF vs. control (SAM analysis). Table S2. IPF vs. control, Ing...
Figure S1. PET parameters were calculated (SUVmean, SUVmax, metabolic lung volume -MLV, total lung g...
MS (top, HDMSE experiment) and MS/MS spectra (bottom, HDMSE experiment) of the metabolic features el...
AGEs-sRAGE correlation in IPF patients during follow-up. IPF patients with a decline of AGEs in seru...
Characteristics of patients and the healthy subjects used for experiments. Data are mean ± standard ...
Locally Weighted Scatterplot Smoothing curves for FVC% predicted. a. Mild physiological impairment (...
Abstract Background The soluble receptor for advanced glycation end-products (sRAGE) has been sugges...
Circulating fibrocyte numbers in patients with IPF and idiopathic pulmonary hypertension (IPAH). (A)...
Heat maps representing the log10-transformed abundance profile (Pareto scaled) of the regulated meta...
Figure S1. (A) Box plot of the RNA integrity number equivalent (RINe) showing distribution of IPF ve...
Table S1. Quality of life scores at each follow-up visit and change in quality of life over the 3-ye...
Table S1. correlation DLCO, lung volumes, cellularity of the BAL, walk distance at 1 year and all PE...
Additional file 1: Figure S1. The forest plot of the Cox univariate and multivariate analyses for TF...
Impaired Diversity of the Lung Microbione Predicts Progression of Idiopathic pulmonary Fibrosis. Tab...
Figure S1. Mean difference in QoL scores for patients with one, two, three and more than three hospi...
Table S1. Top 25 upregulated genes in IPF vs. control (SAM analysis). Table S2. IPF vs. control, Ing...
Figure S1. PET parameters were calculated (SUVmean, SUVmax, metabolic lung volume -MLV, total lung g...
MS (top, HDMSE experiment) and MS/MS spectra (bottom, HDMSE experiment) of the metabolic features el...
AGEs-sRAGE correlation in IPF patients during follow-up. IPF patients with a decline of AGEs in seru...
Characteristics of patients and the healthy subjects used for experiments. Data are mean ± standard ...
Locally Weighted Scatterplot Smoothing curves for FVC% predicted. a. Mild physiological impairment (...
Abstract Background The soluble receptor for advanced glycation end-products (sRAGE) has been sugges...
Circulating fibrocyte numbers in patients with IPF and idiopathic pulmonary hypertension (IPAH). (A)...
Heat maps representing the log10-transformed abundance profile (Pareto scaled) of the regulated meta...
Figure S1. (A) Box plot of the RNA integrity number equivalent (RINe) showing distribution of IPF ve...
Table S1. Quality of life scores at each follow-up visit and change in quality of life over the 3-ye...
Table S1. correlation DLCO, lung volumes, cellularity of the BAL, walk distance at 1 year and all PE...
Additional file 1: Figure S1. The forest plot of the Cox univariate and multivariate analyses for TF...
Impaired Diversity of the Lung Microbione Predicts Progression of Idiopathic pulmonary Fibrosis. Tab...
Figure S1. Mean difference in QoL scores for patients with one, two, three and more than three hospi...
Table S1. Top 25 upregulated genes in IPF vs. control (SAM analysis). Table S2. IPF vs. control, Ing...
Figure S1. PET parameters were calculated (SUVmean, SUVmax, metabolic lung volume -MLV, total lung g...
MS (top, HDMSE experiment) and MS/MS spectra (bottom, HDMSE experiment) of the metabolic features el...